We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




White Matter Hyperintensities Precede Alzheimer's Onset

By MedImaging International staff writers
Posted on 20 Apr 2016
Image: The WMH in the brain of patient with Alzheimer’s disease (Photo courtesy of Adam Brickman/ Columbia University).
Image: The WMH in the brain of patient with Alzheimer’s disease (Photo courtesy of Adam Brickman/ Columbia University).
A new study suggests that autosomal dominant Alzheimer's disease (AD) is associated with increased white matter hyperintensities (WMH) on magnetic resonance imaging (MRI), evident well before symptom onset.
 
Researchers at Columbia University (New York, NY, USA), Washington University School of Medicine (WUSTL; St. Louis, MO, USA), and other institution participating in the Dominantly Inherited Alzheimer Network (DIAN; St. Louis, MO, USA), conducted a study involving 299 participants (median age 39 years), including 184 who had a mutation that results in AD, and 115 of their first-degree relatives who served as non-carrier controls.
 
The researchers than calculated the estimated years to AD from expected symptom onset by subtracting the affected parent's symptom onset age from the participant's age. Baseline MRI data were also analyzed for total and regional WMH. The researchers found that mutation carriers had greater total WMH volumes, which increased approximately six years prior to expected symptom onset. The effects were most prominent for the parietal and occipital lobe, which showed divergent effects as early as 22 years prior to estimated onset. The study was published on March 26, 2016, in Annals of Neurology.
 
“Autosomal dominant Alzheimer's disease is associated with increased WMH well before expected symptom onset,” concluded lead author Seonjoo Lee, PhD, of Columbia University, and colleagues. “The findings suggest the possibility that WMH are a core feature of Alzheimer's disease, a potential therapeutic target, and a factor that should be integrated into pathogenic models of the disease.”
 
The white matter of the brain contains the neuronal fibers that transmit information around the living brain. Historically, the vast majority of neuroscience research effort has been invested in understanding and studying gray matter and neurons, while white matter has received relatively little attention, largely due to the lack of effective research tools to study it, even though it comprises about half the volume of the brain.
 

Related Links: 
 
Columbia University
Washington University School of Medicine
Dominantly Inherited Alzheimer Network
Ultrasound Table
Women’s Ultrasound EA Table
Mammo DR Retrofit Solution
DR Retrofit Mammography
Mammography System (Analog)
MAM VENUS
Mobile X-Ray System
K4W

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.